Research Grants

Research Image

HOPA Research Fund Award: Now Accepting Proposals

The Research Fund Award (RFA) is intended to support a hematology/oncology pharmacy practice research project. Pharmacy practice is broadly defined to include areas of research such as: clinical or patient outcomes, surveys, patient safety, standards validation/benchmarking, and basic/translational science applications.

Proposal Deadline is August 31, 2023

To apply for an RFA Grant, please use the PHS 398 format from the NIH.

Multiple institutions may be involved in the project, and projects with co-principal investigators are allowed. The PI of the proposal must be an active HOPA member.

A subsequent publication resulting from the research project is expected within a year of the study completion. In addition, the awardee is expected to present the results of their research at the HOPA Annual Meeting. The presentation is expected to occur no later than two years after the release of the research funds, as annual conference presentation slots allow.

A total of $100,000 is available to be awarded to up to three grants through a competitive peer-review process. HOPA aims to fund at least one practice-based/clinical and one basic/translational study each year.

Learn more about proposal details, including review criteria. Thank you for your interest in the HOPA Research Fund Award. 

researcher looking into microscope

Check out these research projects that HOPA is proud to have funded through the RFA in recent years. Read more.

micro view of cancer cells

Fuel the HOPA Research Fund. Consider a contribution to HOPA - 100% of proceeds go into the research grant fund. Donate.

Early Career Research Grant

The Early Career Research Grant (ECRG) provides funding to promising investigators early in their career to encourage and promote quality, basic, and pre-clinical translational lab-based research as well as clinical or patient-focused research in hematology/oncology among HOPA members. The purpose of this award is to fund US-based pharmacists within their first 7 years post completion of formal training and have not yet attained R21 (NIH Exploratory/Developmental Research Grant Award) level funding.

Woman working in research

Awarded early career pharmacists will be required to work with a mentor either from their sponsoring institution or to find a mentor from another institution within the United States. The PI of the proposal must also be an active HOPA member.

The Early Career Research Grant will award up to $50,000 to one or two chosen applicants through a competitive peer-review process.

Each year HOPA's call for proposals open in the fall and grants are awarded the following spring. Applications are currently closed.

About HOPA Research Grants

Research Team in Lab

HOPA research grants are intended to provide support for projects that are likely to result in facilitating the efforts of hematology/oncology pharmacists to optimize the care of individuals affected by cancer.

Projects should align closely with the HOPA Strategic Plan Research and Quality goals to support hematology/oncology pharmacist-led research to advance patient care and the profession and to serve as the primary platform for promoting hematology/oncology research and quality results.

Research Grantees

Learn about and take inspiration from HOPA's past research grant award winners.

Clinical Trials

Learn more about participants of HOPA's Industry Relation Council and their current clinical trials.

Publications Collection

If you have been published recently, we want to know about it! Please fill out this short form so we can help you expand your reach by sharing your paper online and through email. This is also a good way for us to know about your subject matter expertise as opportunities for SMEs arise.


The Journal of Hematology Oncology Pharmacy is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacy practitioners and other healthcare professionals with high-quality peer-reviewed information.